Skip to content
  • Join Us
  • Members Area
ASOI
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research

Publication Category: Medications

Glucagon-like peptide 1 (GLP-1) receptor agonists’ use during pregnancy: Safety data from regulatory clinical trials

  • Parker CH, Slattery C, Brennan DJ, le Roux CW. Glucagon-like peptide 1 (GLP-1) receptor agonists’ use during pregnancy: Safety data from regulatory clinical trials Diabetes, Obesity & Metabolism

Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review

  • Al Lawati A, Alhabsi A, Rahul R, Savino ML, Alwahaibi H, Das S, Al Lawati H. Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review Diseases (Basel, Switzerland)

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

  • Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP; SURMOUNT-5 Trial Investigators. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity The New England Journal of Medicine

Global barriers to decision makers for prioritizing interventions for obesity

  • Ehlers LH, Reinstrup NW, Olesen RH, Holm JC, McEwan P, Le Roux CW. Global barriers to decision makers for prioritizing interventions for obesity International Journal of Obesity

A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland

  • Barrett R, Smith A, Gorry C, Doran S, Barry M, McCullagh L. A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland The Journal of the International Society for Pharmaeconomics and Outcomes Research

Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease

  • Sedrak P, Verma R, Verma M, Connelly KA. Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease The Canadian Journal of Cardiology

Factors influencing patients to choose one obesity treatment over another: a qualitative study

  • Craig HC, Alsaeed D, Al Ozairi E, Norris S, Holian J, Kennedy C, Heneghan H, McGillicuddy D, Farrell E, Hollmann E, Al-Najim W, le Roux CW. Factors influencing patients to choose one obesity treatment over another: a qualitative study International Journal of Obesity

Subgroup analysis by sex and baseline BMI in people with a BMI ?27kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist

  • le Roux CW, Steen O, Lucas KJ, Startseva E, Unseld A, Hussain SA, Hennige AM. Subgroup analysis by sex and baseline BMI in people with a BMI ?27kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist Diabetes, Obesity and Metabolism

Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study

  • Le Roux CW, Koroleva A, Larsen S, Foot E. Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study Clin Obes

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration

  • Galofré JC, Díez JJ, Attanasio R, Nagy EV, Negro R, Papini E, Perros P, Žarković M, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Dobnig H, Fadeyev V, Field BCT, Fliers E, Führe Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration J Endocrinol Invest

Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 … Page25 Next →

Recent Posts

  • 9th ASOI Annual Conference – Registration now open!
  • Press Release for World Obesity Day 4th March 2024
  • ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
  • Things to do in Dublin during ECO
  • ECO 2023 sponsorship update

ASOI

  • info@asoi.info
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Privacy Policy
  • Site Map

©2026 ASOI